Morningstar

AbCellera Biologics Inc Ordinary Shares ABCL

Stock XNAS Rating as of Oct 2, 2026

News

AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026

Business Wire Oct 1, 2026, 8:05:00 PM
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

PR Newswire Oct 1, 2026, 4:11:00 PM
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026

Business Wire Sep 16, 2026, 8:05:00 PM
AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

Business Wire Sep 2, 2026, 8:05:00 PM
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Business Wire Aug 13, 2026, 4:05:00 AM
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Business Wire Aug 11, 2026, 8:01:00 PM
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Business Wire Aug 10, 2026, 11:00:00 AM
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

Business Wire Aug 7, 2026, 8:30:00 PM
AbCellera Reports Q2 2026 Business Results

Business Wire Aug 5, 2026, 8:05:00 PM
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

Business Wire Jul 29, 2026, 11:00:00 AM
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

PR Newswire Jul 23, 2026, 1:05:00 PM
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

PR Newswire Jul 15, 2026, 12:45:00 PM
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

Business Wire Jul 7, 2026, 8:05:00 PM
AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Business Wire Jul 6, 2026, 1:00:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.